Clinical trialNCT01897519TerminatedPhase 2Interventional

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

SponsorAbbVieEnrollment56Cardiothoracic SurgeryVascular Surgery

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ann Eldred, MD
AbbVie
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark

Site Reference Id/investigator# 105755
Aarhus N, Denmark
Site Reference Id/investigator# 105757
Kolding, Denmark
Site Reference Id/investigator# 105756
Odense C, Denmark

United States

Site Reference Id/investigator# 96295
Gainesville, Florida, United States
Site Reference Id/investigator# 96778
Jacksonville, Florida, United States
Site Reference Id/investigator# 96301
Tampa, Florida, United States
Site Reference Id/investigator# 96302
Fort Wayne, Indiana, United States
Site Reference Id/investigator# 101961
Indianapolis, Indiana, United States
Site Reference Id/investigator# 103356
Boston, Massachusetts, United States
Site Reference Id/investigator# 96303
Boston, Massachusetts, United States
Site Reference Id/investigator# 96997
Grand Blanc, Michigan, United States
Site Reference Id/investigator# 97878
Petoskey, Michigan, United States
Site Reference Id/investigator# 99377
Royal Oak, Michigan, United States
Site Reference Id/investigator# 99317
West Orange, New Jersey, United States
Site Reference Id/investigator# 96996
New York, New York, United States
Site Reference Id/investigator# 96296
Durham, North Carolina, United States
Site Reference Id/investigator# 102020
Cleveland, Ohio, United States
Site Reference Id/investigator# 103355
Columbus, Ohio, United States
Site Reference Id/investigator# 97556
Pittsburgh, Pennsylvania, United States
Site Reference Id/investigator# 103316
Providence, Rhode Island, United States
Site Reference Id/investigator# 102019
Memphis, Tennessee, United States
Site Reference Id/investigator# 108255
Charlottesville, Virginia, United States
Site Reference Id/investigator# 96300
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

ABT-719Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2013
Primary completion: 31 May 2014
Completion: 31 May 2014
Last update posted: 6 Jun 2014
Registered enrollment: 56
Registry id: NCT01897519

Cross-registrations

EU-CTR / CTIS (EudraCT)2012-005710-19

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.